Dr. Sylke Maas

Sylke Maas, Ph.D. is responsible for Investor Relations and Business Strategy at BioNTech AG. Before taking over this role she has been responsibility for Global Marketing and Sales at BioNTech AG for more than 4 years.

Prior joining BioNTech AG, Sylke was a partner at InterPharmaLink, a consulting pharmaceutical company focused on commercial strategy, enterprise development and partnering. She has over twelve years of experience at Novartis, Sandoz and Hexal in senior positions that included Global Brand Director at Novartis Pharma in Basel/Switzerland, Head Commercial Operations Management Emerging Markets (Asia Pacific, Latin America) at Sandoz International and Head of Business Unit Oncology, Immunology and Biosimilars at Hexal in Germany. Sylke has extensive experience in International Business Operations, Marketing and Sales, Market Access and Portfolio/Life Cycle Management with a focus on retail and specialty market segments.

She holds a Ph.D. and a M.Sc. in pharmacy and has worked in commercial leading positions in Germany and abroad.

Sylke Maas